B. Grabensee

Apolipoprotein B, fibrinogen, HDL cholesterol, and apolipoprotein(a) phenotypes predict coronary artery disease in hemodialysis patients.

Michael Koch, B. Kutkuhn, Evi Trenkwalder et al. · Journal of the American Society of Nephrology · 1997 · 166 citations · Full text

Vascular Disease, Hyperlipidemia, Hemodialysis Patients +20

Relevance of conventional cardiovascular risk factors for the prediction of coronary artery disease in diabetic patients on renal replacement therapy

Michael Koch, F. Gradaus, F. C. Schoebel et al. · Nephrology Dialysis Transplantation · 1997 · 91 citations · Full text

Effects of the angiotensin II antagonist valsartan on blood pressure, proteinuria, and renal hemodynamics in patients with chronic renal failure and hypertension.

J. Plüm, Barbara Bünten, Robert Németh et al. · Journal of the American Society of Nephrology · 1998 · 84 citations · Full text

Hypertension, Hplc Gel-permeation Chromatography, Valsartan Treatment +16

Cardiovascular risk factors and diseases after renal transplantation

Sendogan Aker, Katrin Ivens, B. Grabensee et al. · International Urology and Nephrology · 1998 · 75 citations

Hemodialysis, Urology, Transplantation +10

Single-Dose Kinetics of Recombinant Human Erythropoietin after Intravenous, Subcutaneous and Intraperitoneal Administration

D. Kampf, Anja Kahl, J. Passlick et al. · Contributions to nephrology · 2015 · 52 citations

Intraperitoneal Administration, Translational Medicine, Hematology +4